RxDoctor Payments Data

Jamie Routman

Obstetrics & Gynecology · Birmingham, ALNPI 1275854812

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $632 and has fallen 79.0% since, to $133 in 2023.

$2,241in general payments, 2019–2025

Across 144 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$489
  • Novo Nordisk$377
  • Astellas Pharma US Inc$162
  • Pfizer$157
  • Myovant Sciences Inc.$145
  • Lupin Inc.$130
  • plus $782 from 23 others

What the payments were for

  • Food & beverage$2,15696%
  • Education$854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,241 in reported general payments places this provider in the 60th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama →

Other obstetrics & gynecology in Birmingham

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →